Dienedione, also known as estra-4,9-diene-3,17-dione, is a synthetic, orally active anabolic-androgenic steroid (AAS) of the 19-nortestosterone group that was never introduced for medical use. It is thought to be a prohormone of dienolone.[1] The drug became a controlled substance in the US on January 4, 2010,[2] and is classified as a Schedule III anabolic steroid under the United States Controlled Substances Act. Previous to this, it was sold as a bodybuilding supplement within the United States, and often mistakenly marketed as a prohormone for trenbolone, a veterinary steroid. Prior to its scheduling, it was part of a number of supplements that were seized during FDA enforcement of Bodybuilding.com for selling unapproved new drugs.[3] The actual active metabolite, dienolone, is almost identical to trenbolone structurally, but lacks the C11 double bond.

Dienedione
Clinical data
Other names19-Nor-4,9(10)-androstadienedione; Estradienedione, 19-Norandrosta-4,9(10)-diene-3,17-dione; Estra-4,9(10)-diene-3,17-dione
Routes of
administration
Oral
Legal status
Legal status
Identifiers
  • 13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,17-dione
CAS Number
PubChem CID
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.112.341 Edit this at Wikidata
Chemical and physical data
FormulaC18H22O2
Molar mass270.372 g·mol−1
3D model (JSmol)
  • CC12CCC3=C4CCC(=O)C=C4CCC3C1CCC2=O
  (verify)

See also

edit

References

edit
  1. ^ "Rules - 2009 - Final Rule: Classification of Three Steroids as Schedule III Anabolic Steroids Under the Controlled Substances Act". www.deadiversion.usdoj.gov. Retrieved 1 June 2017.
  2. ^ "Rules - 2009 - Final Rule: Classification of Three Steroids as Schedule III Anabolic Steroids Under the Controlled Substances Act". www.deadiversion.usdoj.gov. Retrieved 1 June 2017.
  3. ^ Office of Regulatory Affairs. "Enforcement Reports - Enforcement Report for July 7, 2010". www.fda.gov. Retrieved 1 June 2017.